Effects of different media on pH and salinity
We analyzed the pH and salinity of the media in each treatment. No differences in pH were observed among the three treatments (Fig. 2). However, the salinity was significantly lower in T2 than in T1.
Effects of different media on the dry weight of the roots
Measurements of the dry weight of the roots were taken to evaluate the effects of different media on root growth. The dry weight of the roots was 2.41 g, 2.57 g, and 3.20 g in T1, T2, and T3, respectively (Fig. 3). The dry weight of the roots was significantly higher in T3 than in T1 and T2.
Qualitative metabolite data
Qualitative data on metabolites were used to analyze changes in metabolites and characterize differences among treatments (Supplementary File 1 and Fig. S1). Across all samples, 736 metabolites from 11 classes were detected (Fig. 4). A total of 128 lipids (17.39%), 96 phenolic acids (13.04%), 79 terpenoids (10.73%), 73 organic acids (9.92%), 70 alkaloids (9.51%), 69 amino acids and derivatives (9.38%), 42 flavonoids (5.71%), 32 nucleotides and derivatives (4.35%), 20 lignans and coumarins (2.72%), 5 quinones (0.68%), and 122 other metabolites (16.58%) were identified. As shown in Fig. S1, all 736 metabolites identified in the samples changed among three treetments. In addition, T2 treatment had a stronger impact on the content of terpenoids, organic acids, alkaloids, phenolic acids and flavonoids.
Principal component analysis (PCA)
Clear separation was observed among all treatments in a PCA score plot of the metabolite data (Fig. 5). Principal component 1 (PC1) explained 25.00% of the total variance in the data, and principal component 2 (PC2) explained 18.56% of the total variance in the data. Although the reproducibility of the data was high, as indicated by the clustering of the metabolite data within each treatment in the PCA score plot, the clear separation among treatments indicates that the content of metabolites differed among treatments.
Quality control (QC) of the PCA data
QC samples were used to evaluate the robustness of the PCA data. Generally, the quality of the data is considered adequate when the PC1 scores are within ±3 standard deviations (SD). In Fig. 6, each point corresponds to a sample, and the horizontal axis indicates the order in which samples were detected. The PC1 scores of all the samples were within ±2 SD, suggesting that the quality of the PC1 data was adequate.
Orthogonal partial least squares discriminant analysis (OPLS-DA)
OPLS-DA can be used to analyze weakly correlated variables. Generally, greater similarity in the distribution of sample points indicates higher similarity in the composition and content of the compounds in the samples. OPLS-DA was used to analyze the effects of different media on the accumulation of 736 metabolites. An effective data classification algorithm is shown in Fig. 7; the sample points in the different groups were clearly separated, suggesting that the composition and content of metabolites varied among media.
Variable importance in projection (VIP)
The VIP score based on the OPLS-DA model was calculated to evaluate the ability of the variables to be discriminated (Mi et al. 2020). In T2, 296 metabolites with VIP > 1 were detected. In T3, 332 metabolites with VIP > 1 were detected. A total of 186 common metabolites in T2 and T3 with VIP > 1 were detected, including 36 lipids, 20 organic acids, 23 phenolic acids, 34 terpenes, 11 alkaloids, 5 amino acids and derivatives, 13 nucleotides and derivatives, and 44 flavonoids, quinones, lignans, coumarins, and other metabolites (Supplementary file 2).
Analysis of differences in the content of metabolites
Fold change values were ordered from largest to smallest to visualize metabolomic differences. We labeled the 10 most significant up-regulated and down-regulated metabolites. The results are shown in Table 1 and Fig. 8. In T2 and T3 treatment, the content of certain alkaloinds, organic acids, phenolic acids, terpenoids, flavonoids, lignans and coumarins changed, which was basically consistent with that in Fig. S1.
Table 1 Dynamic analysis of the difference of metabolite content
|
T2
|
T3
|
|
Compounds
|
Class I
|
Compounds
|
Class I
|
Up-regulated metabolites
|
2,4-Dihydroxyquinoline
|
Alkaloids
|
2,4-Dihydroxyquinoline
|
Alkaloids
|
3-Hydroxy-3-Methyl-2-Oxopentanoic Acid
|
Organic acids
|
3-Hydroxy-3-Methyl-2-Oxopentanoic Acid
|
Organic acids
|
Fortuneanoside A
|
Phenolic acids
|
Fortuneanoside A
|
Phenolic acids
|
2,3,23-Trihydroxyolean-12-en-28-oic acid methyl ester
|
Terpenoids
|
trans-Aconitic acid
|
Organic acids
|
2,3,19-Trihydroxyurs-12-en-28-oic acid (Tormentic acid)
|
Terpenoids
|
4-Nitrophenol
|
Phenolic acids
|
Adenine
|
Nucleotides and derivatives
|
2-Hydroxy-4-methyl-3-tridecanoyloxypentanoic acid methyl ester
|
Lipids
|
7-Hydroxyflavanone
|
Flavonoids
|
Meso-Erythritol
|
Others
|
LysoPE 16:1(2n isomer)
|
Lipids
|
Choline Alfoscerate
|
Lipids
|
Histidinol
|
Alkaloids
|
LysoPE 16:0(2n isomer)
|
Lipids
|
LysoPE 16:0(2n isomer)
|
Lipids
|
Syringetin-7-O-glucoside
|
Flavonoids
|
Down-regulated metabolites
|
Cirsimaritin (4',5-dihydroxy-6,7-dimethoxyflavone)
|
Flavonoids
|
2-Hydroxy-4-methyl-3-undecanoyloxypentanoic acid methyl ester
|
Lipids
|
Aldovibsanin A
|
Terpenoids
|
Thymidine
|
Nucleotides and derivatives
|
Lathyrol
|
Terpenoids
|
6-(((S)-1-carboxyethyl)amino)-4-hydroxyhexanoicacid
|
Amino acids and derivatives
|
Siegesbeckic acid
|
Terpenoids
|
Cyclo(L-Phe-trans-4-hydroxy-L-Pro)
|
Amino acids and derivatives
|
Lambertianic acid
|
Terpenoids
|
Phylloquinone (Vitamin K1)
|
Others
|
6 beta-Hydroxymethandrostenolone
|
Others
|
8-Hydroxy-1,2,6-trimethoxyxanthone
|
Others
|
8-Hydroxy-1,2,6-trimethoxyxanthone
|
Others
|
Glucopyranose 6-Hydroxydecanoate
|
Others
|
Peucedanol 7-O-glucoside
|
Lignans and Coumarins
|
Methyl 3-O-Methyl Gallate
|
Phenolic acids
|
Costunolide(iso-03)
|
Terpenoids
|
O-MethylNaringenin-8-C-arabinoside
|
Flavonoids
|
7-Oxodehydroabietic acid(ISO-1)
|
Terpenoids
|
Hesperetin-7-O-rutinoside (Hesperidin)
|
Flavonoids
|
Screening of DAMs
The 20 metabolites with the highest VIP values are shown in Fig. 9. The details of the DAMs are shown in the figure legend. These DAMs included 17 terpenoids, 5 organic acids, 5 nucleotides and derivatives, 4 lipids, 2 alkaloids, 2 flavonoids, 1 phenolic acid, and 4 others. Up-regulated DAMs included 3-hydroxy-3-methyl-2-oxopentanoic acid, 2,4-dihydroxyquinoline, 2,3,23-trihydroxyolean-12-en-28-oic acid methyl ester, 3-hydroxy-3-methyl-2-oxopentanoic acid, and LysoPC 16:1(2n isomer); all other DAMs were down-regulated.
In Fig. 9a, the metabolites (from up to bottom) are: 7-Oxodehydroabietic acid(ISO-1) (Terpenoids), 8-Hydroxy-1,2,6-trimethoxyxanthone (Others), Costunolide(iso-03) (Terpenoids), 4-Oxoretinoic acid (Organic acids), Siegesbeckic acid (Terpenoids), Cirsimaritin (4',5-dihydroxy-6,7-dimethoxyflavone) (Flavonoids), Dihydroxy-dimethoxyflavone (Flavonoids), Pisiferic acid (Terpenoids), 2,3,23-Trihydroxyolean-12-en-28-oic acid methyl ester (Terpenoids), Methyl abieta (Terpenoids), Lathyrol (Terpenoids), Methyl neoabietate (Terpenoids), Lambertianic acid (Terpenoids), 3-Hydroxy-3-Methyl-2-Oxopentanoic Acid (Organic acids), 9(10)-EpOME;(9R,10S)-(12Z)-9,10-Epoxyoctadecenoic acid (Lipids), phyllanflexoid A (Terpenoids), 6beta-Hydroxymethandrostenolone (Others), LysoPC 16:1(2n isomer) (Lipids), 3-Acetoxy-9,13-epoxy-16-hydroxy-labda-15,16-olide(ISO-1) (Terpenoids), Calliphyllin (Terpenoids).
In Fig. 9b, the metabolites (from up to bottom) are: 3-Hydroxy-3-Methyl-2-Oxopentanoic Acid (Organic acids), Glucopyranose 6-Hydroxydecanoate (Others), 8-Hydroxy-1,2,6-trimethoxyxanthone (Others), Cordycepin (3'-Deoxyadenosine)* (Nucleotides and derivatives), 2'-Deoxyadenosine* (Nucleotides and derivatives), Methyl 3-O-Methyl Gallate (Phenolic acids), 2,4-Dihydroxyquinoline (Alkaloids), Methyl neoabietate* (Terpenoids), Methyl abieta* (Terpenoids), 5'-Deoxyadenosine* (Nucleotides and derivatives), 9,10,13-Trihydroxy-11-Octadecenoic Acid (Lipids), 5(S),15(S)-DiHETE; 5,15-Dihydroxy-6,8,11,13-Eicosatetraenoic Acid (Lipids), Tianshic acid (Organic acids), Siegesbeckic acid (Terpenoids), Calliphyllin (Terpenoids), 2-Aminopurine (Nucleotides and derivatives), Thymine (Nucleotides and derivatives), Lathyrol (Terpenoids), 4-Oxoretinoic acid (Organic acids), 2(3H)-Benzothiazolone (Alkaloids).
KEGG pathway enrichment analysis of DAMs
A KEGG pathway enrichment analysis was conducted on the DAMs (Fig. 10). A total of 22 KEGG pathways were identified. Metabolic pathways, nucleotide metabolism, and biosynthesis of secondary metabolites were essential pathways. Given that secondary metabolites can affect the rhizosphere microenvironment, these KEGG pathways might play a key role in biological processes essential for rhizosphere metabolism.